Table 5.
BMI < 18.5 | BMI ≥ 18.5 | ΔECM/BCM | p-value | |
---|---|---|---|---|
ECM/BCM ratio; median (range) | ||||
T1 | 1.43 (0.47–3.80), n = 16 | 1.05 (0.68–2.25), n = 42 | 26.6% | 0.003 |
T2 | 1.31 (1.10–5.13), n = 12 | 0.97 (0.68–1.39), n = 26 | 26.0% | <0.001 |
T3 | 1.25 (1.05–5.81), n = 7 | 0.97 (0.53–1.50), n = 22 | 22.4% | 0.003 |
T4 | 1.35 (1.04–2.49), n = 3 | 1.04 (0.75–1.23), n = 11 | 22.4% | n.d. |
T5 | 1.34 (1.12–2.90), n = 3 | 1.06 (0.71–1.25), n = 5 | 20.9% | n.d. |
The median observation period per patient was 10.3 months (interquartile range: 0.3; 18.4). Normal range of extracellular mass/body cell mass: < 1.0.
BMI: body mass index; ECM: extracellular mass; BCM: body cell mass; n.d.: not done due to low patient numbers per group.